Wednesday, December 13, 2017

Mad Pride: Making a Truce With the Voices in Your Head

In this piece for Vice, Tess McClure describes New Zealand's Mad Pride movement, a movement that seeks to destigmatize, normalize, and celebrate experiences of voice-hearing...

Scientists Clarify Risks of Augmenting with Antipsychotic Medications for Depression

The researchers found that while antipsychotic drugs may be slightly more effective than alternative antidepressants, they come with a much higher side effect burden.

Study Challenges Assumption that Schizophrenia Impairs Cognitive Ability

Secondary factors may impair performance on cognitive tasks, making it difficult for individuals diagnosed with schizophrenia to perform to the best of their ability.

Children Diagnosed with ADHD Younger are More Likely to get Multiple Medications

New research demonstrates that children diagnosed with ADHD at younger ages are more likely than those diagnosed later to receive multiple medications within five years of their diagnosis.
digital abilify prison

The Orwellian New Digital Abilify Will Subjugate Vulnerable People Across the US

The FDA approved the prescribing and sale of a new hi-tech compliance-monitoring “antipsychotic” drug this week. A new chapter in human darkness has descended — one that is applauded by the alliance of control addicts that made it happen.

Patients on Antipsychotics at High Risk for Cardiovascular Issues, Study Finds

Antipsychotics present a known risk for major side effects. A new study suggests that certain antipsychotics may present a greater risk for cardiovascular disease than others.

The Issue of Over-Diagnosing in Psychiatry

From The Concordian: On October 30th, Dr. Joel Paris, a professor of psychiatry at McGill University, gave a lecture about the dangers and consequences of...

FDA Approves Pill That Digitally Tracks if Patients Have Ingested it

The FDA has approved Abilify MyCite, a pill with a sensor that digitally tracks whether patients have taken their medication. "The system works by sending...

Outcome Reporting Bias in Antipsychotic Medication Trials

A new study in the journal Translational Psychiatry, an influential journal in biological psychiatry published by Nature, challenges the state of the research on antipsychotic drugs.
antipsychotic

Duration of Untreated Psychosis Revisited: Response to the Goff Paper

Based on the studies cited, it seems hard to support the assertion that “early initiation of antipsychotics may improve long-term course of the illness.” This raises an urgent question about initial treatment. Doesn’t it make sense to try to capture all of those individuals who might get through a psychosis without drugs?

Health Care? More Like Health Scare!

From the Lown Institute: For pharmaceutical companies who use scare tactics to sell drugs, every day is like Halloween. This list of egregious advertisements shows...

Researchers Probe Connections Between Physical Activity and ‘Severe Mental Illness’

How does physical activity affect people diagnosed with bipolar, schizophrenia and major depressive disorders?

Psychologists Push For New Approaches to Psychosis: Part 2

The authors of the report expand upon the traumatic and sociopolitical factors underlying presentations of psychosis and “schizophrenia.”

Psychologists Push For New Approaches to Psychosis: Part 1

Psychologists and people with experience of psychotic symptoms publish a report on new ways of understanding psychosis.

New Research Documents Widening Mortality Gap for Bipolar and Schizophrenia

Analysis of longitudinal data from 2000-2014 demonstrate mortality gap is widening between persons with a diagnosis of bipolar or schizophrenia compared to the general population

New Grant Boosts Hearing Voices Approach in USA

From The Foundation for Excellence in Mental Health Care: The Hearing Voices Research and Development Fund has been awarded a $300,000 grant to expand their...

Leading Researchers Critique Current Paradigm for Studying ‘Schizophrenia’ Risk

Re-conceptualizing the Clinical-High-Risk/Ultra-High-Risk Paradigm: A critique and reappraisal

What Happens When You Stop Taking Psychiatric Medications

From Pacific Standard: A new study surveyed people who have come off psychiatric medications to come up with information doctors can use to help support their...
elephant

Psychiatry Ignores an Elephant in the Room

Large cohort studies of people with a first-episode psychosis provide a unique opportunity for finding out why so many young people with schizophrenia spectrum disorders die at a young age. However, it seems that those psychiatrists who have access to the mortality data generally do not want the facts to come out.

Researchers Question Add-On Treatment for ‘Schizophrenia’

A common practice when antipsychotics are found to be ineffective for schizophrenia is to prescribe a second, additional psychoactive medication. Now, a new study suggests that this practice is not supported by the research.

Deprescribing: How to be on Less Medication for Healthier Aging

In this post for Better Health While Aging, Dr. Leslie Kernisan discusses the importance of making sure that older adults are taking the minimum amount...

Inappropriate Use of Antipsychotics on Adults with Intellectual and Developmental Disabilities

One-third of adults with an intellectual or developmental disability are dispensed antipsychotics, despite having no existing psychiatric diagnosis.

Abilify: The Drug That Could Gamble Your Life Away

On this episode of America's Lawyer, Mike Papantonio discusses the numerous lawsuits pending involving the anti-psychotic drug Abilify, which has caused plaintiffs to develop serious...

Study Identifies Cause of Weight Gain From Antipsychotic Drugs

From UPI: A team of researchers from the University of Texas Southwestern Medical Center found that the serotonin 2c receptor is responsible for weight gain...

Vanda Puts Antipsychotic Side Effect Front and Center in TV Ads

From FiercePharma: Vanda Pharmaceuticals, which makes the antipsychotic drug Fanapt, has recently rolled out a national TV campaign to raise awareness of akathisia. The company...

Follow Us

19,639FansLike
10,825FollowersFollow
1,527SubscribersSubscribe